"Topline results are anticipated to be available one week after database lock, with full analysis to follow." ...8/12
"Based on information received from the data management and biostatistics vendors, study unblinding, analysis of the unblinded data and release of topline study results for the Brilacidin COVID-19 trial is anticipated to occur in mid-to-late October." ...9/23